← Evidence map

SynthesisJAMA network open2022

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.

Yichen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35947385